February 11, 2020 / 11:58 AM / 17 days ago

BRIEF-Health Canada Has Approved Taltz For The Treatment Of Active Ankylosing Spondylitis

Feb 11 (Reuters) - Eli Lilly and Co:

* HEALTH CANADA HAS APPROVED TALTZ® (IXEKIZUMAB) FOR THE TREATMENT OF ACTIVE ANKYLOSING SPONDYLITIS (RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS)

* ELI LILLY CANADA SAYS HEALTH CANADA APPROVED TALTZ ON FEB 4, 2020, FOR TREATMENT OF ADULT PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below